GE HealthCare Technologies Inc.(GEHC)Earnings, Financials & Key RatiosGE HealthCare Technologies Inc. (GEHC) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
while the stock trades at a forward P/E of 13.47, the inconsistent operating cash flow to net income ratio of 0.75 in 2026Q1 suggests that core earnings quality remains insufficient to justify a more aggressive valuation.
GE HealthCare Technologies Inc. (GEHC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
GE HealthCare Technologies Inc. (GEHC) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 29, 2026 | $0.99vs $1.04-4.8% | $5.1Bvs $5.0B+1.8% |
| Q1 2026 | Feb 4, 2026 | $1.44vs $1.40+2.9% | $5.7Bvs $5.6B+1.5% |
| Q4 2025 | Oct 29, 2025 | $1.07vs $1.05+1.9% | $5.1Bvs $5.1B+1.1% |
| Q3 2025 | Jul 30, 2025 | $1.06vs $0.92+15.5% | $5.0Bvs $5.0B+0.7% |
Recent stock market news and headlines for GE HealthCare Technologies Inc. (GEHC)
Futures are trading lower after a mixed start to trading on Monday, following the holiday-shortened week due to the Juneteenth Federal holiday.
GE HealthCare expands its Carilion Clinic collaboration with AAMP and Encompass to improve equipment management and operational efficiency across Virginia.
Key metrics vs top competitors for GE HealthCare Technologies Inc. (GEHC)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $64.89 | $29.52B | 14.26 | 4.84% | 10.1% | 21.65% | 0.21% | |
| $313.38 | $120.14B | 37.31 | 11.16% | 13.21% | 15.1% | — | |
| $45.30 | $67.33B | 23.35 | 19.87% | 17.23% | 14.67% | — | |
| $94.82 | $54.6B | 51.81 | 11.55% | 17.34% | 10.54% | — | |
| $28.23 | $26.88B | 26.56 | -1.04% | 5.49% | 8.96% | — | |
| $76.01 | $16.97B | 30.53 | 1.74% | 13.18% | 11.01% | — |
GE HealthCare Technologies Inc. (GEHC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
GE HealthCare Technologies Inc. (GEHC) SEC filings — annual & quarterly reports (10-K, 10-Q)
Apr 29, 2026·SEC
Mar 17, 2026·SEC
Feb 27, 2026·SEC
Get notified when GEHC posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
GE HealthCare Technologies Inc. (GEHC) stock FAQ — growth, dividends, profitability & financials explained
GE HealthCare Technologies Inc. (GEHC) reported $19.95B in revenue for fiscal year 2025. This represents a 16% increase from $17.16B in 2020.
GE HealthCare Technologies Inc. (GEHC) grew revenue by 4.8% over the past year. Growth has been modest.
Yes, GE HealthCare Technologies Inc. (GEHC) is profitable, generating $1.50B in net income for fiscal year 2025 (10.1% net margin).
Yes, GE HealthCare Technologies Inc. (GEHC) pays a dividend with a yield of 0.21%. This makes it attractive for income-focused investors.
GE HealthCare Technologies Inc. (GEHC) has a return on equity (ROE) of 21.6%. This is excellent, indicating efficient use of shareholder capital.
GE HealthCare Technologies Inc. (GEHC) generated $1.52B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
